RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
58 hedge funds and large institutions have $104M invested in Repros Therapeutics Inc. in 2015 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 19 closing their positions.
Holders
58
Holders Change
-6
Holders Change %
-9.38%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
13
Reduced
17
Closed
19
Calls
$12.7M
Puts
$3.38M
Net Calls
+$9.31M
Net Calls Change
+$9.09M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$5.39M |
| 2 |
PA
2
Perceptive Advisors
New York
|
$1.64M |
| 3 |
OAM
3
Oxford Asset Management
Oxford,
United Kingdom
|
$908K |
| 4 |
4
Barclays
London,
United Kingdom
|
$924K |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$5.67M |
